Arvinas Patents Clause Samples
The "Arvinas Patents" clause defines which patents are considered to be owned or controlled by Arvinas for the purposes of the agreement. It typically lists or describes the specific patents, patent applications, or patent rights that fall under this definition, and may include both existing and future patents related to certain technologies or products. This clause ensures clarity about the scope of intellectual property covered, helping to avoid disputes over which patents are included in licensing, collaboration, or other contractual arrangements.
Arvinas Patents. Arvinas shall have the sole and exclusive right, at its discretion and expense, to Prosecute and Maintain Patents within the Arvinas Intellectual Property (other than Joint New Intellectual Property and Deliverables New Intellectual Property, which shall be Prosecuted and Maintained pursuant to Section 8.3.1 above); provided that Arvinas shall not file any patent application that expressly claims or otherwise discloses the Deliverables, Optimization Deliverables, or any PROTAC or Product that in either case contains a Genentech Compound without the prior written consent of Genentech, which consent shall not be unreasonably withheld or delayed. In accordance with Section 8.3.4 below, Arvinas shall appropriately consult with Genentech with respect to any such Prosecution or Maintenance to the extent relevant to Licensed PROTACs or Licensed Products directed to Exclusive Targets or to Licensee’s rights under Sections 3.3 or 8.2.7(a) of this Agreement.
Arvinas Patents. Confidential Materials omitted and filed separately with the Securiites and Exchange Commission. A total of 2 pages were omitted. [**]
Arvinas Patents. Confidential Materials omitted and filed separately with the Securiites and Exchange Commission. A total of 2 pages were omitted. [**] Appendix 1.11.2-1 CONFIDENTIAL EXECUTION COPY Exhibit 1.40 Excluded Targets Target [**] [**] Exhibit 1.40-1 CONFIDENTIAL EXECUTION COPY Exhibit 1.74 Initial Targets Target [**] [**] Exhibit 1.74-1 CONFIDENTIAL EXECUTION COPY Exhibit 2.10.2(b) Expansion Targets as of A&R Effective Date Target [**] [**] Exhibit 2.10.2(b)-1 Exhibit 10.1
Arvinas Patents. Subject to the rest of this Section 3.2, Arvinas is the sole Controlling Party for the Prosecution and Maintenance of Arvinas Patents, and Arvinas will consult with ▇▇▇▇▇, with respect to such Prosecution and Maintenance of Arvinas Patents. Arvinas will be responsible for [**] percent ([**]%) of all Prosecution Costs incurred in connection with such Prosecution and Maintenance activities.
Arvinas Patents. Subject to Section 9.3(e), as between the Parties, Arvinas shall [**] prepare, file, prosecute (including the defense of any oppositions, interferences, reissue proceedings, reexaminations and other post-grant proceedings originating in a patent office) and maintain the Arvinas Patents in any jurisdiction in the Territory using counsel of its choice. Arvinas shall periodically inform Pfizer of all material steps with regard to the preparation, filing, prosecution and maintenance of the relevant Arvinas Patents in the Territory and shall provide Pfizer with an opportunity to review and comment on substantive prosecution matters in a timely fashion.